Waning treatment is a warning for all ‘one-and-done’ therapies – STAT
With companies promoting the idea of “one-and-done” gene therapies — and setting prices accordingly — patient advocates hope companies will be more wary.
Related Articles
At NIH, ‘everyone is on edge’ as they brace for deep cuts and more centralized control
As the NIH braces for cuts of up to 5,000 of its 20,000 positions, “people are scrambling and freaking out,” a researcher said.
CDC’s reported study on vaccines and autism could test RFK Jr.’s pledges to a key senator
Bill Cassidy said RFK Jr. pledged to keep communication lines wide open and to consult with the senator on vaccine policy.
UK plan to require drug makers to pay higher rebates draws criticism from industry group
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service. U.K. pharma is not happy.
Should health care providers tell patients they are using AI?
This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health and medicine.
Telehealth platforms in senators’ crosshairs over relationship with Eli Lilly, Pfizer
Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.
Dr. Oz pledges Medicare Advantage scrutiny: ‘There is a new sheriff in town’
Oz mentioned risk coding and prior authorizations as areas he plans to examine in Medicare Advantage.
In the Boston area, biotech’s hub, a slump is being acutely felt
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
I’m head of an NGO in Kenya. The shutoff of USAID support has been devastating
“There is a pervasive sense of fear — of losing access to critical health care services and of livelihoods lost,” CFK Africa Executive Director Jeffrey…
At NIH, ‘everyone is on edge’ as they brace for deep cuts and more centralized control
As the NIH braces for cuts of up to 5,000 of its 20,000 positions, “people are scrambling and freaking out,” a researcher said.
Get 50% off an annual STAT+ subscription
Join the STAT+ community today and enjoy unlimited access to award-winning journalism, premium data tools, discounted event tickets, and much more.